Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
Add more filters










Publication year range
1.
J Forensic Leg Med ; 97: 102551, 2023 Jul.
Article in English | MEDLINE | ID: mdl-37339573

ABSTRACT

PURPOSE: In cases of drowning, the presence of sphenoid sinus fluid is a non-specific autopsy finding. However, studies have reported that fluid accumulation in the paranasal sinuses is more commonly observed in drowning victims. Furthermore, some laboratory tests, such as diatom and electrolyte analysis, can serve as supplementary diagnostic tools for diagnosing drowning. Therefore, accurate sphenoid sinus fluid sampling is an important aspect of an autopsy in suspected drowning cases. The aim of this study was to identify the significance of evaluating sphenoid sinus fluid by PMCT images in cases of drowning. METHODS: We retrospectively reviewed 54 drowning victims who underwent PMCT and forensic autopsy. Fluid volume in the sphenoid sinus was measured using a graduated syringe during autopsy and a three-dimensional (3D) workstation based on PMCT images was used for the purpose of comparison. The Mann-Whitney U test and Spearman's rank correlation coefficient was used to evaluate statistically significant differences and correlations. Additionally, a Bland-Altman plot was employed to assess the agreement between PMCT and autopsy. RESULTS: The median volume was 1.65 (range 0.00-12.4) ml and 1.55 (range 0.00-7.00) ml in the PMCT and autopsy, respectively, showing a statistically insignificant difference (p = 0.294) and a significant correlation (Rs = 0.896). In 35 cases, the PMCT overestimated the fluid volume more than the autopsy, whereas in 14 cases, the PMCT underestimated the fluid volume. No fluid was identified in seven cases during the autopsy, whereas in five patients, no fluid was found in both PMCT and autopsy. By analyzing the Bland-Altman plot, a bias of 0.73 ± 1.4 ml and limits of agreement ranging from -2.04 to 3.51 ml were observed for sphenoid sinus fluid volume measurements. CONCLUSIONS: Based on the limitations of traditional fluid volume measurement in the sphenoid sinus during autopsy, we propose the utilization of PMCT volumetric analysis prior to autopsy as a means to enhance the detection of sphenoid sinus fluid in cases of drowning.


Subject(s)
Body Fluids , Drowning , Postmortem Changes , Sphenoid Sinus , Sphenoid Sinus/diagnostic imaging , Sphenoid Sinus/pathology , Drowning/diagnostic imaging , Drowning/pathology , Tomography, X-Ray Computed , Humans , Body Fluids/chemistry , Body Fluids/diagnostic imaging , Middle Aged
2.
J Forensic Leg Med ; 78: 102124, 2021 Feb.
Article in English | MEDLINE | ID: mdl-33516145

ABSTRACT

MicroRNAs have various characteristics, including stability, and tissue and disease specificity. One of the important issues in forensics is that biomarkers can differ quantitatively depending on the sampling site. We aimed at evaluating the differences in microRNA levels in the post-mortem (PM) blood from different sampling sites. The study subjects comprised seventeen males and eleven females. The number of cardiac deaths (CD) and non-cardiac deaths (NCD) was eleven and seventeen, respectively. A cardiopulmonary resuscitation (CPR) was performed in fifteen cases. Venous blood was obtained from the external iliac vein for peripheral blood (PB), inferior vena cava for pre-cardiac blood (CB), and coronary sinus for post-cardiac blood (coronary sinus blood, CSB). The selected target microRNAs were cardiac-specific (miR208 and miR-1) and non-cardiac microRNAs (miR-16 and let-7e). The levels of miR-208b and miR-1 in the PM blood differed according to its sampling site and showed an increasing order of tendency in the PB, CB, and CSB. However, these variations according to sampling sites did not correlate with the post-mortem interval and the levels did not differ between the CD and NCD groups, and between the CPR and non-CPR groups. MiR-16 and let-7e levels did not vary according to the sampling site. The present study confirms that the cardiac-specific microRNA levels in the PM blood from different sampling sites are different. In addition, this study showed that the characteristics of target microRNAs, such as tissue-specificity, should be considered and the sampling site for microRNAs should be presented in forensic applications.


Subject(s)
MicroRNAs/blood , Adult , Aged , Aged, 80 and over , Autopsy , Biomarkers/blood , Female , Humans , Male , Middle Aged , Organ Specificity , Proof of Concept Study
3.
Neuropathology ; 33(3): 288-91, 2013 Jun.
Article in English | MEDLINE | ID: mdl-22978513

ABSTRACT

Here we report a case of a biphasic tumor consisting of pilocytic astrocytoma with anaplastic solitary fibrous tumor component in the pineal region. The majority of the tumor showed typical histologic features of pilocytic astrocytoma. A minor part of the tumor showed marked proliferation of short spindle cells around vessels. These spindle cells showed CD34 and CD99 immunoreactivity. From a review of the literature, we found that only one similar case has been reported. Contrary to the reported case, our case showed anaplastic features of solitary fibrous tumor histology.


Subject(s)
Astrocytoma/pathology , Carcinoma/pathology , Neoplasms, Fibrous Tissue/pathology , Pinealoma/pathology , 12E7 Antigen , Antigens, CD/metabolism , Antigens, CD34/metabolism , Astrocytoma/therapy , Carcinoma/therapy , Cell Adhesion Molecules/metabolism , Chemoradiotherapy , Combined Modality Therapy , Female , Humans , Immunohistochemistry , Magnetic Resonance Imaging , Middle Aged , Neoplasm Recurrence, Local , Neoplasms, Fibrous Tissue/therapy , Neurosurgical Procedures/methods , Pinealoma/therapy
4.
Yonsei Med J ; 53(3): 667-9, 2012 May.
Article in English | MEDLINE | ID: mdl-22477016

ABSTRACT

The syndrome of inappropriate antidiuretic hormone secretion has only been reported in a few patients with large cell neuroendocrine carcinoma (LCNEC); however, it has never been reported in a patient with LCNEC of the lung, whose serum sodium levels were normalized after surgical resection of the mass. A 63-year-old male presented with a two-day history of dizziness and recent memory loss. On admission, his serum sodium level was 113 mEq/L with a serum osmolality of 236 mosm/kg, a urine osmolality of 441 mosm/kg, and a urine sodium level of 65 mEq/L. His chest computed tomography revealed a 2.7×2.3 cm-sized mass in the left lower lobe. After surgical removal of the mass, his serum sodium concentrations were normalized, and histopathology of the mass revealed LCNEC.


Subject(s)
Carcinoma, Large Cell/pathology , Carcinoma, Neuroendocrine/pathology , Inappropriate ADH Syndrome/pathology , Humans , Male , Middle Aged
5.
J Gastroenterol Hepatol ; 27(8): 1306-11, 2012 Aug.
Article in English | MEDLINE | ID: mdl-22414232

ABSTRACT

BACKGROUND AND AIM: Primary hepatic neuroendocrine carcinomas (PHNECs) are extremely rare, with only about 150 cases having been reported in the English-language literature. Because of the rarity of PHNECs, its clinical features and treatment outcomes are not well understood. Here, we report our experiences with PHNECs. METHODS: We identified patients diagnosed with PHNEC and analyzed their demographics, baseline laboratory data, tumor characteristics, treatment modalities and outcomes. RESULTS: A total of 218 consecutive patients were identified with pathologically confirmed neuroendocrine carcinoma. Of these, 12 patients were diagnosed with PHNECs; the median age was 66.5 years (range, 37 to 80 years), and seven patients (58.3%) were male. Two patients who each had a single hepatic mass underwent curative surgical resection. One patient who was of inoperable status at the initial diagnosis because of multiple intrahepatic metastases showed a partial response after the ninth round of systemic chemotherapy and then underwent surgical resection. The median overall survival in the 12 patients was 16.5 months (range, 0.7 to 41.7 months). Three patients who underwent surgical treatment are alive without recurrence for 15.2 months, 18.0 months, and 36.9 months, respectively. CONCLUSIONS: Primary hepatic neuroendocrine carcinoma should be considered as a possible differential diagnosis in the management of hepatic tumors. The liver can be the primary origin of neuroendocrine tumors, and if the tumors are diagnosed as primary hepatic neuroendocrine tumors, surgical resection must be considered for curative treatment.


Subject(s)
Carcinoma, Neuroendocrine/diagnosis , Carcinoma, Neuroendocrine/therapy , Liver Neoplasms/diagnosis , Liver Neoplasms/therapy , Adult , Aged , Aged, 80 and over , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Biopsy , Carcinoma, Neuroendocrine/mortality , Carcinoma, Neuroendocrine/pathology , Chemoembolization, Therapeutic , Chemotherapy, Adjuvant , Female , Hepatectomy , Humans , Kaplan-Meier Estimate , Liver Neoplasms/mortality , Liver Neoplasms/pathology , Male , Middle Aged , Neoadjuvant Therapy , Predictive Value of Tests , Retrospective Studies , Time Factors , Tomography, X-Ray Computed , Treatment Outcome
6.
APMIS ; 119(12): 868-76, 2011 Dec.
Article in English | MEDLINE | ID: mdl-22085363

ABSTRACT

There is no scientific evidence to support the idea that serial sectioning along the short axis of the lymph node is superior to a single bisection along the long axis. We mathematically evaluated methods of lymph node dissection and applied the result to six lymph nodes that had produced false negative results at the time of frozen examination. We simplified the geometry of a lymph node to that of a three-dimensional ellipse and compared two different cutting methods. Let A be the cross-sectional area obtained through a single bisection along the long axis, and let B be the sum of the cross-sectional areas of n fragments obtained via serial cutting along the short axis. The smallest n (n*) that makes a B larger than A can be calculated. n* = [3L + √9L² + 16S²)/4S]. ([α], the smallest integer greater than or equal to α; L, long axis; S, short axis). The probabilities of tumor detection when the node is bisected along the long axis (P(D(A)|E)) and when serially cut along the short axis (P(D(B)|E)) are as follows. P(D(A)|E = {(3/2)S² - 3ST + T²}T/(S - T)³. and P(D(B)|E) = (n - 1){(1 + 1/n)L² - 3LT + T²}T/(L - T)³. (T, size of the tumor cell cluster). According to these formulas, three out of six lymph nodes were not examined in the most appropriate manner.


Subject(s)
Lymph Node Excision/methods , Sentinel Lymph Node Biopsy , Humans , Models, Theoretical , Probability
7.
Korean J Urol ; 51(8): 579-82, 2010 Aug.
Article in English | MEDLINE | ID: mdl-20733966

ABSTRACT

Retroperitoneal liposarcoma is an infrequent, locally aggressive malignancy. We report two cases of huge retroperitoneal liposarcomas. The presence of a palpable abdominal mass was a common symptom of the two patients. Preoperative imaging study showed huge retroperitoneal tumors. Both patients underwent complete surgical resections, and a negative microscopic margin was achieved in both cases. The histopathologic diagnosis was a well-differentiated retroperitoneal liposarcoma. Neither of the two patients developed a recurring tumor during the 1.5 years of follow-up.

9.
Korean J Gastroenterol ; 55(4): 256-60, 2010 Apr.
Article in Korean | MEDLINE | ID: mdl-20389180

ABSTRACT

Behcets disease is a multisystemic inflammatory disease characterized with recurrent oral ulcer, genital ulcer, and multiple organ involvement. Aplastic anemia is one of the rarest complications of Behcets disease. There were only several reports about Behcets disease associated myelodysplatic syndrome worldwide. Moreover, aplastic anemia in intestinal Behcets disease was rarely reported. Here, we present a case of aplastic anemia with trisomy 8 and trisomy 9 in intestinal Behcets disease and a review of the literatures. To the authors knowledge, this is the first case ever reported in Korea.


Subject(s)
Anemia, Aplastic/diagnosis , Behcet Syndrome/diagnosis , Intestinal Diseases/diagnosis , Trisomy , Adult , Anemia, Aplastic/complications , Behcet Syndrome/complications , Behcet Syndrome/genetics , Bone Marrow/pathology , Chromosomes, Human, Pair 8 , Chromosomes, Human, Pair 9 , Female , Humans , Intestinal Diseases/complications , Intestinal Diseases/genetics , Karyotyping , Tomography, X-Ray Computed
11.
Ann Clin Lab Sci ; 39(4): 392-8, 2009.
Article in English | MEDLINE | ID: mdl-19880768

ABSTRACT

Therapy-related myelodysplastic syndrome and acute leukemia after treatment with temozolomide have rarely been described in the literature. Only 10 cases in association with temozolomide have been documented. The cases included anaplastic astrocytoma (4 cases), anaplastic oligodendroglioma (2 cases), low grade astrocytoma (2 cases), low grade oligodendroglioma (1 case), and one case of secondary Philadelphia-positive acute lymphoblastic leukemia in a patient with glioblastoma multiforme. Here we report a novel case of therapy-related myelodysplastic syndrome/acute myeloid leukemia associated with der(1;7)(q10;p10) in a glioblastoma multiforme patient treated with temozolomide. Results of bone marrow morphology, chromosome, and fluorescent in situ hybridization (FISH) analyses, as well as the clinical history, strongly suggest a treatment-related etiology in our case. In past reports, karyotypes in cases of therapy-related myelodysplastic syndrome/acute myeloid leukemia mostly demonstrated abnormalities in chromosomes 5 and 7. However, we report a case of temozolomide-related myelodysplastic syndrome/acute myeloid leukemia with der(1;7)(q10;p10), possibly the first reported case, to the authors' knowledge.


Subject(s)
Dacarbazine/analogs & derivatives , Glioblastoma/drug therapy , Leukemia, Myeloid, Acute/chemically induced , Myelodysplastic Syndromes/chemically induced , Adult , Aged , Biopsy , Bone Marrow Cells/pathology , Brain Neoplasms/drug therapy , Brain Neoplasms/pathology , Dacarbazine/adverse effects , Dacarbazine/therapeutic use , Disease Progression , Female , Glioblastoma/pathology , Humans , In Situ Hybridization, Fluorescence , Karyotyping , Leukemia, Myeloid, Acute/complications , Magnetic Resonance Imaging , Male , Middle Aged , Myelodysplastic Syndromes/complications , Skin/pathology , Temozolomide
12.
Water Res ; 39(10): 2178-88, 2005 May.
Article in English | MEDLINE | ID: mdl-15921722

ABSTRACT

The photodegradation capability of DDT has been enhanced by Fe/TiO2 film in a photoreactor with UV radiation. The optimal thickness of TiO2 for the DDT photodegradation was 2.94 microm with a 3-time coating, where the first-order rate constant was 0.077 min(-1). The optimal Fe3+(ferric ion) photodeposition amount was estimated as 3.7 x 10(-4) mg mm(-2) corresponding with 0.73 mg Fe3+ (mg TiO2)(-1). Photoremoval rate of DDT increased with an increasing pH value, while the pH value of solution decreased to acidic region during the DDT photodegradation. The photodegradation efficiency was 85% in 20 min with only TiO2 film and increased from 85% up to 96% by the photodeposition of 0.73 mg Fe3+ (mg TiO2)(-1) on TiO2 film as a sensitizer since the band gap energy of Fe2O3 (2.2 eV) is lower than that of TiO2 (3.0 eV).


Subject(s)
DDT/metabolism , Iron/chemistry , Photochemistry , Titanium/chemistry , Water Purification/methods , Biodegradation, Environmental , Cations , DDT/isolation & purification , Ferric Compounds/chemistry , Hydrogen-Ion Concentration , Kinetics
SELECTION OF CITATIONS
SEARCH DETAIL
...